Harnessing the motion sensors of a smartphone solves critical issues in health care resourcing and timely access to specialized tests in heart failure.

How digital strategies can overcome barriers in screening heart diseases.

Patented advances in gyrocardiography bring affordable, clinical-grade disease detection to remote patients with smartphones.

CardioSignal and Mehiläinen, a well-known private provider of social and healthcare services in the Nordics, have formed a successful population health model to advance earlier detection of atrial fibrillation, a massive health care burden in the society today and a significant cause of hospitalization among older adults.

To break barriers in the scalability and accessibility of remote cardiac care technology among older adults, CardioSignal has become a portfolio company of AgeTech Collaborative™ from AARP® after completing its prestigious accelerator program.

Lasse Leppäkorpi, an entrepreneur, investor, and advisor with over 20 years of experience in health technology business development and biomedical engineering, has joined the CardioSignal team to boost the company’s international expansion.